Hangzhou Jiuyuan Gene Engineering Co .,Ltd
Hangzhou
About Hangzhou Jiuyuan Gene Engineering Co .,Ltd
Hangzhou Jiuyuan Gene Engineering develops and sells biochemical and chemical pharmaceuticals and other medical equipment. Their products include filgrastim, oprelvekin, enoxaparin sodium, palonosetron, and recombinant human bone morphogenetic protein. Their drug pipeline mainly includes liraglutide, fulvestrant, fosaprepitant, and pegfilgrastim.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1,001 – 5,000
- Estimated revenue: $100K – $500K
- Total funding: $2.0M
- Funding stage: IPO
- Last round: Series A (Jun 2012)
- Ticker: hkg:2566
- Website: china-gene.com
- Phone: 0571-86910099
Industries & Categories
Chemical, Health Care, Manufacturing, Medical Device, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/hangzhou-jiuyuan-gene-engineering-co-ltd-73056 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.